The NHS Confederation–the membership organisation for healthcare providers in England, Wales and Northern Ireland– has just released a quite comprehensite 45-page whitepaper titled Maximising the potential of digital in mental health. Some of the highlights: To do nothing is not an option. If we don’t make more progress we miss a key opportunity to make…
Read MoreThere is mounting recognition in the scientific community that combining different treatment approaches for mental health conditions can create a benefit greater than the sum of its parts. As a clinical psychologist and neuroscience researcher, I have been working to integrate insights from both fields to expand treatment options for those suffering from depression, anxiety and…
Read MoreThe impact of physical exercise on ADHD has been examined in a large number of studies. Collectively, these studies have examined whether exercise reduces on core ADHD symptoms, e.g., inattention and hyperactivity/impulsivity, and strengthens executive functions, e.g., inhibitory control, working memory, and mental health, e.g., emotional and social functioning. Overall, results across multiple studies suggest…
Read MoreThe FDA has approved Leqembi, the first disease-modifying treatment for early-stage Alzheimer’s and a precursor condition, mild cognitive impairment. Medicare has said it will pay for the therapy. Medical centers across the country are scrambling to finalize policies and procedures for providing the medication to patients, possibly by summer’s end or early autumn. It’s a…
Read MoreNeurotechnologies – devices that interact directly with the brain or nervous system – were once dismissed as the stuff of science fiction. Not anymore. Several companies are trying to develop brain-computer interfaces, or BCIs, in hopes of helping patients with severe paralysis or other neurological disorders. Entrepreneur Elon Musk’s company Neuralink, for example, recently received…
Read MoreThe real costs of the new Alzheimer’s drug, Leqembi — and why taxpayers will foot much of the bill (CBS News): The first drug purporting to slow the advance of Alzheimer’s disease is likely to cost the U.S. health care system billions annually even as it remains out of reach for many of the lower-income seniors…
Read MoreApple Invents a next-generation AirPods Sensor System that could measure Biosignals and Electrical Activity of a User’s brain (Patently Apple): Today the US Patent & Trademark Office published a patent application from Apple that relates to a next-generation of AirPods Sensor System wherein the housing and tips of AirPods could include a number of active and…
Read MoreConcern as a third of NHS mental health treatments shift online (The Guardian): An Observer analysis of data from private providers, cross-checked against NHS figures, reveals around one in three mental health treatments in England are delivered online, up from one in five in 2019, and one in 10 in 2017. Patients with mild to…
Read MoreMasterclass: Boost Your Mental Fitness & Resilience to Thrive in the Modern Workplace
SHARPBRAINS Advisors is an independent think-tank and consulting firm providing services at the frontier of applied neuroscience, health, leadership and sustainability. Learn more about our upcoming Masterclass: Boost your Mental Fitness & Resilience to Thrive in the Modern Workplace.